Berkshire Hathaway BRK.B
SEC filings (XBRL) · quarterly · fiscal year ends December 31
Pick a second metric to compare.
Source: SEC EDGAR 10-Q/10-K XBRL, CIK 1067983; every value is traced to its filing on EDGAR. Retrieved Oct 11, 2026. Quarters labelled by fiscal quarter with the calendar period end. Q4 = annual minus Q1–Q3; cash-flow quarters derived from year-to-date figures.
Last 84 quarters
| Q3 2024Sep 30, 2024 | Q4 2024Dec 31, 2024 | Q1 2025Mar 31, 2025 | Q2 2025Jun 30, 2025 | Q3 2025Sep 30, 2025 | Q4 2025Dec 31, 2025 | Q1 2026Mar 31, 2026 | Q2 2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $93.0B | $94.9B | $89.7B | $92.5B | $95.0B | $94.2B | $93.7B | $101.8B |
| Operating income | — No figure for Q3 2024: no candidate tag (OperatingIncomeLoss) on the income statement of 0000950170-24-120241 (R4.htm); the statement presents no such line | — No figure for Q4 2024: no candidate tag (OperatingIncomeLoss) on the income statement of 0000950170-25-025210 (R4.htm); the statement presents no such line | — No figure for Q1 2025: no candidate tag (OperatingIncomeLoss) on the income statement of 0000950170-25-063112 (R4.htm); the statement presents no such line | — No figure for Q2 2025: no candidate tag (OperatingIncomeLoss) on the income statement of 0000950170-25-101578 (R4.htm); the statement presents no such line | — No figure for Q3 2025: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-25-261548 (R4.htm); the statement presents no such line | — No figure for Q4 2025: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-26-083899 (R4.htm); the statement presents no such line | — No figure for Q1 2026: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-26-202243 (R4.htm); the statement presents no such line | — No figure for Q2 2026: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-26-341032 (R4.htm); the statement presents no such line |
| Net income | $26.3B | $19.7B | $4.6B | $12.4B | $30.8B | $19.2B | $10.1B | $25.7B |
| Capital spending | $4.7B | $5.3B | $4.3B | $4.9B | $5.6B | $6.2B | $5.0B | $5.6B |
| Operating cash flow | $1.8B | $4.6B | $10.9B | $10.1B | $13.8B | $11.2B | $10.4B | $11.2B |
| Free cash flow | −$2.9B | −$0.7B | $6.6B | $5.2B | $8.2B | $5.0B | $5.5B | $5.6B |
| Capex / operating cash flow | 260.7% | 115.7% | 39.3% | 48.2% | 40.5% | 55.4% | 47.8% | 50.3% |
| Shares outstanding | 1.329B | 1.339B | 1.343B | 1.379B | 1.373B | 1.390B | 1.399B | 1.409B |
| Share count change, y/y | – | – | – | – | – | – | – | – |
| Diluted shares (weighted avg.) | — No figure for Q1 2024–Q3 2024: no reported 3-month diluted weighted-average fact | — No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | — No figure for Q1 2025–Q3 2025: no reported 3-month diluted weighted-average fact | — No figure for Q1 2025–Q3 2025: no reported 3-month diluted weighted-average fact | — No figure for Q1 2025–Q3 2025: no reported 3-month diluted weighted-average fact | — No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | — No figure for Q1 2026–Q2 2026: no reported 3-month diluted weighted-average fact | — No figure for Q1 2026–Q2 2026: no reported 3-month diluted weighted-average fact |
Operating income: Not presented by the company: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-17-160889 (R4.htm); the statement presents no such line.
Shares outstanding: Not presented by the company: total across classes not reported as one line; per-class counts shown as filed.
— Diluted shares (weighted avg.): No figure for Q1 2024–Q3 2024: no reported 3-month diluted weighted-average fact
— Diluted shares (weighted avg.): No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
— Diluted shares (weighted avg.): No figure for Q1 2025–Q3 2025: no reported 3-month diluted weighted-average fact
— Diluted shares (weighted avg.): No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
— Diluted shares (weighted avg.): No figure for Q1 2026–Q2 2026: no reported 3-month diluted weighted-average fact
Diluted shares (weighted avg.): fiscal Q4 is blank because the 10-K gives 12-month figures only; some quarters blank: No 3-month diluted weighted-average value in XBRL for this quarter.
Shares outstanding is the total across share classes: a simple sum of share counts, with each class listed above.
XBRL tags used
| Revenue | Revenues | Mar 2017 to Jun 2026 |
|---|---|---|
| Operating income | Not presented by the company: no candidate tag (OperatingIncomeLoss) on the income statement of 0001193125-17-160889 (R4.htm); the statement presents no such line | |
| Net income | NetIncomeLoss | Mar 2017 to Jun 2026 |
| Capital spending | PaymentsToAcquirePropertyPlantAndEquipment | Mar 2017 to Jun 2026 |
| Operating cash flow | NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Free cash flow | ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment | Mar 2017 to Jun 2026 |
| Capex / operating cash flow | capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Shares outstanding | dei:EntityCommonStockSharesOutstanding | Mar 2017 to Jun 2026 |
| Diluted shares (weighted avg.) | Blank: no clean reported value in the filings | |
Where a company changed tags, each quarter uses the tag it was reported under; the newest tag is primary.